The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy
Tsutomu Iwata(Aichi Medical University), Midori Shimada(Yamaguchi University), Seiji Ishiguro, Yoshikazu Johmura(Kanazawa University), Ayako Koyama(Nagoya City University), Makoto Nakanishi(The Cancer Institute Hospital), Takuya Saito(Aichi Medical University), K. Koyama(Aichi Medical University), Shunichiro Komatsu(Nagoya University), Tsuyoshi Sano(Aichi Medical University), Masahiko Miyachi(Nagoya University), Takashi Arikawa(Aichi Medical University), Tairin Uchino(Aichi Medical University)
Cited by 13
Related Papers
Navigating the DNA methylation landscape of cancer
|Trends in Genetics|2021|1k
Aberrant cell cycle checkpoint function and early embryonic death in <i>Chk1</i><sup>−/−</sup> mice
|Genes & Development|2000|469
Chk2‐deficient mice exhibit radioresistance and defective p53‐mediated transcription
|The EMBO Journal|2002|436